| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 737.50M | 655.90M | 767.80M | 645.50M | 548.70M |
| Gross Profit | 708.70M | 655.90M | 598.40M | 538.80M | 438.50M |
| EBITDA | 187.40M | 0.00 | 190.10M | 172.70M | 150.80M |
| Net Income | 54.20M | 60.90M | 48.00M | 56.80M | 41.90M |
Balance Sheet | |||||
| Total Assets | 1.34B | 1.14B | 1.19B | 1.17B | 999.30M |
| Cash, Cash Equivalents and Short-Term Investments | 30.40M | 27.60M | 42.50M | 50.70M | 41.70M |
| Total Debt | 654.50M | 535.80M | 535.40M | 570.20M | 490.30M |
| Total Liabilities | 791.30M | 675.40M | 687.10M | 725.90M | 632.20M |
| Stockholders Equity | 546.00M | 466.30M | 501.90M | 445.20M | 367.10M |
Cash Flow | |||||
| Free Cash Flow | -11.90M | 600.00K | 63.20M | -24.70M | -40.20M |
| Operating Cash Flow | -4.50M | 24.80M | 85.80M | -900.00K | -24.80M |
| Investing Cash Flow | -35.20M | -24.10M | -22.60M | -23.50M | -15.20M |
| Financing Cash Flow | 40.70M | -12.60M | -72.70M | 27.20M | -32.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £221.14M | 5.11 | 8.33% | 5.33% | -11.17% | 6.04% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £558.09M | 9.42 | 10.35% | 4.39% | -7.52% | 50.23% | |
62 Neutral | £12.07M | 4.32 | 14.61% | 3.33% | 8.91% | 94.32% | |
61 Neutral | £185.50M | 2.44 | -965.56% | 4.74% | ― | ― | |
53 Neutral | £277.48M | 24.71 | 1.89% | ― | -3.77% | -147.20% | |
48 Neutral | £31.95M | -9.86 | -450.00% | ― | -97.14% | 98.49% |